1. Mice endometrium receptivity in early pregnancy is impaired by maternal hyperinsulinemia
   Runqin Li et al, 2017 CrossRef
2. Mechanistic target of rapamycin: integrating growth factor and nutrient signaling in the collecting duct
   Aaron L. Brown et al, 2018, American Journal of Physiology-Renal Physiology CrossRef
3. An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function
   Yimamu Maimaitili et al, 2018, Leukemia Research CrossRef
4. mTOR: A Cellular Regulator Interface in Health and Disease
   Fahd Boutouja et al, 2019, Cells CrossRef
5. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
   Meena Jhanwar-Uniyal et al, 2019, Adv Biol Regul CrossRef
6. Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo
   Jonas Elias Schweig et al, 2019, J. Biol. Chem. CrossRef
7. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects
   Meena Jhanwar-Uniyal et al, 2017, Advances in Biological Regulation CrossRef
8. Involvement of mTOR Pathways in Recovery from Spinal Cord Injury by Modulation of Autophagy and Immune Response
   Ingrid Vargova et al, 2021, Biomedicines CrossRef
9. Defining the role of mTOR pathway in the regulation of stem cells of glioblastoma
   Meena Jhanwar-Uniyal et al, 2022, Advances in Biological Regulation CrossRef
10. From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
    Brittany Dewdney et al, 2023, Sig Transduct Target Ther CrossRef
11. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets
    Meena Jhanwar-Uniyal et al, 2024, Cells CrossRef
12. Phosphatidic acid as a cofactor of mTORC1 in platinum-based chemoresistance: mechanisms and therapeutic potential
    Hadi Alizadeh et al, 2024, European Journal of Pharmacology CrossRef